Kidney NGAL is a novel early marker of acute injury following transplantation

Star RA (1998) Treatment of acute renal failure. Kidney Int 54:1817–1831

Schrier RW, Wang W, Poole B, Mitra A (2004) Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114:5–14

Lamiere N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365:417–430

Molitoris BA (2003) Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 14:265–267

Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14:2199–2210

Siegel NJ, Shah SV (2003) Acute renal failure: directions for the next decade. J Am Soc Nephrol 14:2176–2177

Devarajan P (2005) Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr 17:193–199

Schrier RW (2004) Need to intervene in established acute renal failure. J Am Soc Nephrol 15:2756–2758

Hewitt SM, Dear J, Star RA (2004) Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 15:1677–1689

Herget-Rosenthal S, Marggraf G, Hüsing J, Goring F, Pietruck F, Janssen O, Phillip T, Kribben A (2004) Early detection of acute renal failure by serum cystatin C. Kidney Int 66:1115–1122

Rabb H (2003) Novel urinary markers for early diagnosis of ARF. Am J Kidney Dis 42:599–600

Bellomo R, Kellum JA, Ronco C (2004) Defining acute renal failure: physiological principles. Intensive Care Med 30:33–37

Perico N, Cattaneo D, Sayegh MH, Remuzzi G (2004) Delayed graft function in kidney transplantation. Lancet 364:1814–1827

Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL (1997) Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63:968–974

Koning OH, Ploeg RJ, van Bockel H, Groenewegen M, van der Woude FJ, Persijn GG, Hermans J (1997) Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. Transplantation 63:1620–1628

Jacobs SC, Cho E, Foster C, Liao P, Bartlett ST (2004) Laparoscopic donor nephrectomy: the University of Maryland 6-year experience. J Urol 171:47–51

Lu CY, Penfield JG, Kielar ML, Vasquez MA, Jeyarajah DR (1999) Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int 55:2157–2168

Sayegh MH (1999) Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 65:1967–1979

Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC (2000) Delayed graft function influences renal function, but not survival. Kidney Int 58:859–866

Giral-Classe M, Hourmant M, Cantarovich D, Dantal J, Blancho G, Daguin P, Ancelet D, Soulillou JP (1998) Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 54:972–978

Shoskes DA, Cecka M (1998) Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 66:1697–1701

Troppman C, Gruessner AC, Gillingham KJ, Sutherland DE, Matas AJ, Gruessner RW (1999) Impact of delayed graft function on long-term graft survival after solid organ transplantation. Transplant Proc 31:1290–1292

Woo YM, Jardine AG, Clark AF, MacGregor MS, Bowman AW, Macpherson SG, Briggs JD, Junor BJ, McMillan MA, Rodger RS (1999) Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 55:692–699

Tejani AH, Sullivan EK, Alexander SR, Fine RN, Harmon WE, Kohaut EC (1999) Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 3:293–300

Prommool S, Jhangri GS, Cockfield SM, Halloran PF (2000) Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 11:565–573

Halloran PF, Hunsicker LG (2001) Delayed graft function: state of the art, Nov 10–11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 1:115–120

Salahudeen AK, Haider N, May W (2004) Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 65:713–718

Irish WD, McCollum DA, Tesi RJ, Owen AB, Brennan DC, Bailly JE, Schnitzler MA (2003) Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 14:2967–2974

Brier ME, Ray PC, Klein JB (2003) Prediction of delayed renal allograft function using an artificial neural network. Nephrol Dial Transplant 18:2655–2659

Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P (2003) Differential gene expression following early renal ischemia–reperfusion. Kidney Int 63:1714–1724

Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of NGAL as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 4:2534–2543

Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS (2003) Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery and novel therapeutics. Mol Genet Metab 80:365–376

Oberbauer R, Rohrmoser M, Regele H, Mulhbacher F, Mayer G (1999) Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10:2006–2013

Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, Tellis V, Devarajan P (2003) Activation of mitochondrial apoptotic pathways in human allografts after ischemia–reperfusion injury. Transplantation 76:50–54

Schwarz C, Regele H, Steininger R, Hansmann C, Mayer G, Oberbauer R (2001) The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation 71:1666–1670

Yang J, Goetz D, Li J-Y, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, Barasch J (2002) An iron delivery pathway mediated by a lipocalin. Mol Cell 10:1045–1056

Gwira JA, Wei F, Ishibe S, Ueland JM, Barasch J, Cantley LG (2005) Expression of NGAL regulates epithelial morphogenesis in vitro. J Biol Chem 280:7875–7882

Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P (2004) Amelioration of ischemic acute renal injury by NGAL. J Am Soc Nephrol 15:3073–3082

Mori K, Lee HT, Rapoport D, Drexler I, Foster K, Yang J, Schmidt-Ott, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J (2005) Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia. J Clin Invest 115:610–621

Salmela K, Wramner L, Ekberg H, Hauser I, Bentdal O, Lins LE, Isoniemi H, Backman L, Persson N, Neumayer HH, Jorgensen PF, Spieker C, Hendry B, Nicholls A, Kirste G, Hasche G (1999) A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimobab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation 67:729–736

Acker CG, Flick R, Shapiro R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Greenberg A, Johnson JP (2002) Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant 2:57–61

Hladunewich MA, Corrigan G, Derby GC, Ramaswamy D, Kambham N, Scandling JD, Myers BD (2003) A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF. Kidney Int 64:593–602

Schwarz A, Gwinner W, Hiss M, Radermacher J, Mengel M, Haller H (2005) Safety and adequacy of renal transplant protocol biopsies. Am J Transplant 5:1992–1996

Heilman RL, Mazur MJ, Reddy KS, Moss A, Post D, Mulligan D (2005) Steroid avoidance immunosuppression in low-risk kidney transplant. Transplant Proc 37:1785–1788

Sakai K, Miyagi Y, Hasegawa T, Itabashi Y, Muramatsu M, Sugiyama K, Kawamura T, Arai K, Aikawa A, Ohara T, Mizuiri S, Hasegawa A (2005) The pathologic impact of tacrolimus on protocol biopsy in renal transplant patients with basiliximab-based immunosuppression. Transplant Proc 37:1757–1759

Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 365:1231–1238

Morrow DA, Braunwald E (2003) Future of biomarkers in acute coronary syndrome: Moving toward a multimarker strategy. Circulation 108:250–252

Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P (2004) Neutrophil gelatinase-associated lipocalin (NGAL): a novel urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24:307–315